Inventor · disambiguated record
Fabio Maria Sabbatini
Also filed as: SABBATINI FABIO · SABBATINI FABIO MARIA
8 granted patents·13 pending applications·51 citations·filing 1997–2022
80Inventor score
Top patents by PatentIndex Score
21 records- 0176US6479488B1Tetrahydroquinoline derivatives as EAA antagonistsGLAXO WELLCOME SPA·Filed 1997·Granted Nov 12, 2002·45 cites·11 claims
- 0267US7427630B2Condensed N-heterocyclic compounds and their use as CRF receptor antagonistsSB PHARMACO PUERTO RICO INC·Filed 2004·Granted Sep 23, 2008·5 cites·18 claims
- 0361US9687789B2Ultrafiltration for preparing outer membrane vesiclesOLIVIERI ROBERTO·Filed 2004·Granted Jun 27, 2017·1 cites·15 claims
- 0458US11427558B1Indazoles and azaindazoles as LRRK2 inhibitorsESCAPE BIO INC·Filed 2020·Granted Aug 30, 2022·0 cites·18 claims
- 0555US2023077268A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2022·Application pending·0 cites
- 0652US2017252699A1Ultrafiltration for preparing outer membrane vesiclesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 0751US2011172255A1Condensed N-Heterocyclic Compounds and their Use as CRF Receptor AntagonistsSB PHARMCO INC·Filed 2007·Application pending·0 cites
- 0847US2010286151A11-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating DisordersBENTLEY JONATHAN·Filed 2008·Application pending·0 cites
- 0946US2004087020A1Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal originCHIRON SPA·Filed 2003·Application pending·0 cites
- 1045US12503452B2Antimicrobial compounds and methodsCURZA GLOBAL LLC·Filed 2020·Granted Dec 23, 2025·0 cites·30 claims
- 1144US9284526B2Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal originOLIVIERI ROBERTO·Filed 2004·Granted Mar 15, 2016·0 cites·4 claims
- 1242US2023148214A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2021·Application pending·0 cites
- 1342US2010286152A1N-phenyl hydrazides as modulators of the ghrelin receptorGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1441US2007066640A1Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonistsCASTIGLIONI EMILIANO·Filed 2004·Application pending·0 cites
- 1540US11085017B2Process for propagating a yeast capable to ferment glucose and xyloseVERSALIS SPA·Filed 2017·Granted Aug 10, 2021·0 cites·18 claims
- 1640US2010216821A1Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 AntagonistsBARTON NICHOLAS PAUL·Filed 2008·Application pending·0 cites
- 1740US2023072397A1Antimicrobial Compounds and MethodsCURZA GLOBAL LLC·Filed 2020·Application pending·0 cites
- 1839US2022162192A1Indazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2020·Application pending·0 cites
- 1938US11155838B2Process to produce a fermentation productVERSALIS SPA·Filed 2017·Granted Oct 26, 2021·0 cites·17 claims
- 2038US2009203705A1Spiro Compounds As NPY Y5 Receptor AntagonistsBIAGETTI MATTEO·Filed 2009·Application pending·0 cites
- 2134US2021261553A1Fused tetrazoles as lrrk2 inhibitorsE SCAPE BIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabio Maria Sabbatini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →